ENCER is an emerging pharmaceutical company dedicated to the research, development, and commercialization of proprietary products designed to address the side effects of cancer treatment.
The company has developed a safe, clinically approved homeopathic solution for cancer treatment-related fatigue. The non-chemical product can be used in conjunction with conventional cancer treatments without causing any additional side effects.
Cumulative Funding Raised Over Time ($)
Employees Over Time
ENCER Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 22, 2021
pubmed.ncbi.nlm.nih.gov
Attention Dysregulation in Breast Cancer Patients Following a Complementary Alternative Treatment Routine: A Double-Blind Randomized Trial
#Not applicable
Jun 19, 2019
clinicaltrials.gov
Assessment of Fatigue During Radiotherapy for Breast Cancer With and Without Homeopathy Treatment - Tabular View - ClinicalTrials.gov
undefined
Jun 5, 2018
pubmed.ncbi.nlm.nih.gov
Feasibility of Homeopathic Treatment for Symptom Reduction in an Integrative Oncology Service
undefined
Nov 2, 2017
www.sciencedirect.com
Plant-derived nanoparticle treatment with cocc 30c ameliorates attention and motor abilities in sleep-deprived rats